Cargando…

Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis

OBJECTIVE: The objective of our study is to investigate the Fc glycosylation profiles of both antigen-specific IgG targeted against proteinase 3 (PR3-ANCA) and total IgG as prognostic markers of relapse in patients with Granulomatosis with Polyangiitis (GPA). METHODS: Seventy-five patients with GPA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kemna, Michael J., Plomp, Rosina, van Paassen, Pieter, Koeleman, Carolien A.M., Jansen, Bas C., Damoiseaux, Jan G.M.C., Cohen Tervaert, Jan Willem, Wuhrer, Manfred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360573/ https://www.ncbi.nlm.nih.gov/pubmed/28169190 http://dx.doi.org/10.1016/j.ebiom.2017.01.033

Ejemplares similares

Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study
por: Slot, Marjan C, et al.
Publicado: (2006)

T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?
por: Wilde, Benjamin, et al.
Publicado: (2010)

Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study
por: Ysermans, Renée, et al.
Publicado: (2022)

Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise
por: Wojcik, Iwona, et al.
Publicado: (2023)

Patients with non-relapsing ANCA-associated vasculitis have increased numbers of circulating IL-10 producing Th17 cells
por: Wilde, B, et al.
Publicado: (2010)

Variability of serum IgG sialylation and galactosylation degree in women with advanced endometriosis
por: Sołkiewicz, Katarzyna, et al.
Publicado: (2021)

Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies
por: Sonneveld, Myrthe E., et al.
Publicado: (2018)

Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3)
por: Plomp, Rosina, et al.
Publicado: (2015)

Endothelial progenitor cells are differentially impaired in ANCA-associated vasculitis compared to healthy controls
por: Wilde, B., et al.
Publicado: (2016)

A novel glycosidase plate-based assay for the quantification of galactosylation and sialylation on human IgG
por: Rebello, Osmond D., et al.
Publicado: (2020)

Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans
por: Dekkers, Gillian, et al.
Publicado: (2016)

Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets
por: van Osch, Thijs L.J., et al.
Publicado: (2022)

Automatic Reading of ANCA-Slides: Evaluation of the AKLIDES System
por: Damoiseaux, Jan, et al.
Publicado: (2012)

The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells
por: Werner, Kai, et al.
Publicado: (2019)

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
por: van Dam, Laura S, et al.
Publicado: (2020)

CD4(+)CD28(null) T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis
por: Slot, Marjan C., et al.
Publicado: (2017)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional study
por: van Eeden, Charmaine, et al.
Publicado: (2023)

Abnormal N‐glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake
por: Treacy, Eileen P., et al.
Publicado: (2021)

Rhinologic and sinonasal changes in PR3 ANCA pulmonary vasculitis
por: Zycinska, K, et al.
Publicado: (2010)

Clinical implications of serum thrombomodulin in PR3-ANCA-associated vasculitis
por: Zycinska, K, et al.
Publicado: (2009)

Acute PR3-ANCA vasculitis in an asymptomatic COVID-19 teenager
por: Wintler, Taylor, et al.
Publicado: (2021)

Infection is associated with increased risk of MPO- but not PR3-ANCA-associated vasculitis
por: Rathmann, Jens, et al.
Publicado: (2022)

mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
por: Buhre, Jana Sophia, et al.
Publicado: (2023)

Positron Emission Tomography scanning in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis
por: Kemna, Michael J., et al.
Publicado: (2015)

Membrane expression of neutrophil proteinase 3 (PR3) is associated with relapse in PR3-ANCA related vasculitis
por: Rarok, AA, et al.
Publicado: (2002)

Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement
por: Zycinska, K, et al.
Publicado: (2009)

Chemokine/Cytokine Levels Correlate with Organ Involvement in PR3-ANCA-Associated Vasculitis
por: Müller-Deile, Janina, et al.
Publicado: (2021)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study
por: van de Geijn, Fleur E, et al.
Publicado: (2009)

B Lineage Cells in ANCA-Associated Vasculitis
por: Merino-Vico, Ana, et al.
Publicado: (2021)

IgG1 Fc N-glycan galactosylation as a biomarker for immune activation
por: de Jong, Sanne E., et al.
Publicado: (2016)

Reactivity against Complementary Proteinase-3 Is Not Increased in Patients with PR3-ANCA-Associated Vasculitis
por: Tadema, Henko, et al.
Publicado: (2011)

The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)

Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-associated vasculitis of the appendix
por: Leaver, Phillip J, et al.
Publicado: (2019)

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

Factors affecting IgG4-mediated complement activation
por: Oskam, Nienke, et al.
Publicado: (2023)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019)

ANCA Testing in Clinical Practice: From Implementation to Quality Control and Harmonization
por: Damoiseaux, Jan
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4sscr18m3ht9p3r85kh9gl8sb9